Articles
28.07.2020
SMC restarts medicines appraisals process

The SMC has recently announced that it is beginning to restart its medicines appraisal process in a ...

Read more
Articles
15.07.2020
What are payer archetypes

Payers are responsible for making choices on which products or services to fund from limited healthc...

Read more
Articles
24.06.2020
Changes to NICE single technology appraisals

NICE has decided to adapt the technical engagement step in a hope to improve stakeholder inclusion, ...

Read more
Articles
23.06.2020
COVID-19 impact on pricing and market access

Without a doubt, the impact of COVID-19 will influence all sectors, including the future of market a...

Read more
Articles
11.06.2020
What is real-world evidence

Real-world evidence refers to clinical and economic evidence which has been derived from the analysi...

Read more
Articles
02.06.2020
Artificial intelligence in market access

AI technologies are becoming increasingly relevant in many fields, such as business and marketing an...

Read more
Articles
28.05.2020
Scottish Medicines Consortium (SMC)

NICE has announced they will begin a phased restart of publishing guidance, whilst SMC meetings are ...

Read more
Articles
20.05.2020
International Reference Pricing

IRP is a pricing mechanism where the price of a drug in one country is set or adjusted in relation t...

Read more
Articles
12.05.2020
Price and market access price affected by COVID

We received fabulous feedback, with responses from at least 15 industry executives across global pha...

Read more
Articles
05.05.2020
Remote delivery of market access training

Whilst many businesses are currently working remotely, up-skilling your workforce through interactiv...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.